Reproductive Decision‐Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing
Prenatal Diagnosis · 2026-04 · 46 (4) · 514-522
DOI: 10.1002/pd.70111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 02.03.2026. Verfasst von Marta D'Alonzo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Gynaecology and Obstetrics Unit, Mauriziano Umberto I Hospital, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Preimplantation Diagnosis, Prenatal Diagnosis, Genetic Testing, Attitude of Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The objective of this paper is to investigate the knowledge and attitudes of BRCA1/2 pathogenic variant carriers and gynecologists regarding preimplantation genetic tests for monogenic diseases (PGT‐M) and prenatal diagnosis (PND).
Methods
A survey using structured questionnaires was completed by 89 BRCA1/2 carriers and 37 gynecologists, assessing awareness, attitudes, and ethical concerns.
Results
Before receiving information, only 28% of carriers were aware of PGT‐Mand PND. Once informed, the majority believed that these options should be discussed with all BRCA mutation carriers as part of standard reproductive counseling (87.6% for PGT‐M and 85.7% for PND). Many indicated a willingness to consider their use. Nonetheless, concerns remained, particularly regarding hormonal stimulation, pregnancy termination, and ethical implications. Among gynecologists, awareness of PGT‐M and PND as options for BRCA carriers was inconsistent (45.9% and 51.4%, respectively), and few routinely discussed these options with patients. Ethical concerns were common, and 86.5% of clinicians expressed the need for clearer guidelines and multidisciplinary collaboration.
Conclusion
The findings reveal a discrepancy between reproductive preferences of BRCA mutation carriers and current practices and knowledge among healthcare professionals. Bridging this gap will require educational efforts, development of guidelines, and a multidisciplinary approach to reproductive counseling in the context of hereditary cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, Gynaecology and Obstetrics Unit, Mauriziano Umberto I Hospital, University of Turin, Turin, Italy.
Zitieren
APA
D'Alonzo, M., Actis, S., Lavalle, G., Suraci, S., Pace, L., Bounous, V. E., & Ferrero, A. (2026). Reproductive Decision‐Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing. Prenatal Diagnosis, 46(4), 514-522. https://doi.org/10.1002/pd.70111
Vancouver
D'Alonzo M, Actis S, Lavalle G, Suraci S, Pace L, Bounous VE, et al. Reproductive Decision‐Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing. Prenatal Diagnosis. 2026;46(4):514-522. doi:10.1002/pd.70111
BibTeX
@article{DAlonzo2026,
author = {D'Alonzo, Marta and Actis, Silvia and Lavalle, Giulia and Suraci, Simona and Pace, Luca and Bounous, Valentina Elisabetta and Ferrero, Annamaria},
title = {Reproductive Decision‐Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing},
journal = {Prenatal Diagnosis},
year = {2026},
volume = {46},
number = {4},
pages = {514--522},
doi = {10.1002/pd.70111}
}
EUVIMED